Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prime Medicine (PRME) Capital Expenditures: 2021-2025

Historic Capital Expenditures for Prime Medicine (PRME) over the last 4 years, with Sep 2025 value amounting to $247,000.

  • Prime Medicine's Capital Expenditures fell 80.66% to $247,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $6.0 million, marking a year-over-year decrease of 17.85%. This contributed to the annual value of $7.3 million for FY2024, which is 16.39% down from last year.
  • Prime Medicine's Capital Expenditures amounted to $247,000 in Q3 2025, which was down 84.29% from $1.6 million recorded in Q2 2025.
  • Prime Medicine's 5-year Capital Expenditures high stood at $4.8 million for Q4 2022, and its period low was $247,000 during Q3 2025.
  • For the 3-year period, Prime Medicine's Capital Expenditures averaged around $1.8 million, with its median value being $1.8 million (2023).
  • Per our database at Business Quant, Prime Medicine's Capital Expenditures skyrocketed by 1,160.21% in 2022 and then crashed by 80.66% in 2025.
  • Quarterly analysis of 5 years shows Prime Medicine's Capital Expenditures stood at $382,000 in 2021, then surged by 1,160.21% to $4.8 million in 2022, then slumped by 61.78% to $1.8 million in 2023, then declined by 2.66% to $1.8 million in 2024, then slumped by 80.66% to $247,000 in 2025.
  • Its last three reported values are $247,000 in Q3 2025, $1.6 million for Q2 2025, and $2.4 million during Q1 2025.